Amidst the current efforts to prove early intervention might have benefits in moderate aortic stenosis (AS), this trial comes along directing us back to basics. In patients with symptomatic aortic stenosis, peaking mortality will clearly justify intervention. But what is the case when there are no symptoms? According to this recent analysis published in JAMA,...
One-month dual antiplatelet therapy (DAPT) in patients undergoing acute coronary syndrome (ACS) did not reach the safety and efficacy results observed in the general population of the original trial STOPDAPT-2. The STOPDAPT-2 ACS compared one-month DAPT followed by clopidogrel monotherapy for one year vs. one-year DAPT after PCI. Initially, the study enrolled mostly stable patients...
01- TAVR and Anticoagulation: Direct Anticoagulant Agents or Vitamin K Inhibitors? In some patients, using an anticoagulant agent is not an option, it is just prescribed. Based on the French TAVR registry, this research compared long-term mortality, bleeding, and ischemic events after valve implantation. A comparison was made between TAVR and direct vs. classic anticoagulant agents—good old proven and reversible vitamin K inhibitors. Read also HERE 02-...
01- ESC 2021 | Updated European Society of Cardiology Guidelines for the Management of Valvular Heart Disease Early intervention in asymptomatic valvular heart disease, age recommendations to decide between TAVR and surgery for aortic stenosis, and a push in favor of transcatheter repair in secondary mitral regurgitation are some of the new modifications to the European...
Early detection of coronary artery disease (CAD) using computed tomography (CT) and calcium score (CAC) might help plan prevention strategies years in advance. This study used CT to determine the prevalence and characteristics of atherosclerosis in the general population. Non-contrast images were scored for CAC. After that, all images with atherosclerosis potential were assessed segment...
This registry of daily clinical practice suggests that this specifically designed double-mesh carotid stent is safe and associated with a minimal and acceptable occurrence of neurological events up to 12 months of follow-up. This double-mesh stent has already been tested, and its short- and long-term efficacy has been proven. However, more recent data have challenged the...
In patients at high risk of bleeding undergoing coronary stenting with a Xience stent, 1-to-3-month DAPT period resulted non-inferior to a 6-to-12-month period in terms of ischemic events, and this could be associated to a lower rate of major bleeding and lower stent thrombosis incidence. There is no longer an indication for conventional stents in...
✔️ Watch again the session “Current & Immediate Future Role of Imaging in Structural and Coronary Heart Disease” in the SOLACI-CACI 2021 Congress. 👨🏫 Program: 02:27 – Computer Tomography in TAVR: Planning, Predicting Complications, and Follow-up – Mariano Falconi 19:26 – Multi-Imaging Evaluation in Mitral Regurgitation Intervention – Fabián Salmo 31:10 – New Prognosis Tools...
Paravalvular regurgitation after transcatheter aortic valve replacement (TAVR) have historically been associated with worse clinical outcomes. Even mild leaks have been shown to be harmful. This study looked at a real-world experience with the transcatheter heart valve SAPIEN 3 Ultra in the US. The SAPIEN 3 Ultra is a new generation balloon-expandable heart valve with...
✔️ Watch again “SOLACI Research” session carried out during SOLACI-CACI 2021. At the event, important advances of LATAM Bif and SOLACI Peripheral registries were shared and SOLACI / SIAC guidelines on TAVR vs CABG were presented. We also featured 2 important presentations by doctors Sanjit Jolly (Canada) and Deephak Bhatt (USA) 👨🏫 Program: 00:01 –...